1. Michelle A Rudek PharmD PhD, at time of writing, BS, Pre-doctoral
Fellow, Clinical Pharmacology Research Core, National Cancer Institute, Bethesda, MD;
now, Research Associate, Division of Medical Oncology, The Sidney Kimmel Comprehensive
Cancer Center at Johns Hopkins, Baltimore, MD
2. Kenneth S Bauer Jr PharmD PhD, at time of writing, Fellow, Clinical
Pharmacology Research Core, National Cancer Institute; now, Assistant Professor,
Pharmacy Practice and Science, University of Maryland School of Pharmacy,
Baltimore
3. Richard M Lush III PhD, at time of writing, Fellow, Clinical
Pharmacology Research Core, National Cancer Institute; now, Director, Clinical Research
Unit, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
4. Sherman F Stinson PhD, Senior Scientist, Developmental Therapeutics
Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at
Frederick, Frederick, MD
5. Adrian M Senderowicz MD, at time of writing, Coordinator, Developmental
Therapeutics Program, Clinical Trials Unit, National Cancer Institute; now, Chief,
Molecular Therapeutics Unit, Oral and Pharyngeal Cancer Branch, National Institute of
Dental and Craniofacial Research, Bethesda
6. Donna J Headlee RN, Research Nurse, Medical Oncology Clinical Research
Unit, Center for Cancer Research, National Cancer Institute
7. Susan G Arbuck MD, at time of writing, Section Chief, Investigational
Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute; now, Vice
President and Global Head, Oncology Therapeutic Area, Aventis Pharmaceuticals,
Bridgewater, NJ
8. Michael C Cox PharmD, Clinical Fellow, Clinical Pharmacology Research
Core, National Cancer Institute
9. Anthony J Murgo MD, Senior Investigator, Investigational Drug Branch, Cancer Therapy
and Evaluation Program, National Cancer Institute
10. Edward A Sausville MD PhD, Associate Director, Developmental
Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer
Institute
11. William D Figg PharmD, Senior Investigator, Head, Molecular Pharmacology
Section, Cancer Therapeutics Branch; Head, Clinical Pharmacology Research Core, Medical
Oncology Clinical Research Unit, National Cancer Institute